Imani Moise reports on TerraWolf’s partnership with Anthropic to build a Kentucky AI campus and its sale of a joint venture stake. SK Hynix lowered its U.S. listing fundraising target to $28.2 billion, aiming to expand chip facilities. Meanwhile, Novartis agreed to pay up to $1.5 billion for MyrixBio to strengthen its oncology drug portfolio.